Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial - PubMed (original) (raw)
Clinical Trial
. 2000 Mar 1;283(9):1167-74.
doi: 10.1001/jama.283.9.1167.
Affiliations
- PMID: 10703779
- DOI: 10.1001/jama.283.9.1167
Clinical Trial
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial
R Nduati et al. JAMA. 2000.
Abstract
Context: Transmission of human immunodeficiency virus type 1 (HIV-1) is known to occur through breastfeeding, but the magnitude of risk has not been precisely defined. Whether breast milk HIV-1 transmission risk exceeds the potential risk of formula-associated diarrheal mortality in developing countries is unknown.
Objectives: To determine the frequency of breast milk transmission of HIV-1 and to compare mortality rates and HIV-1-free survival in breastfed and formula-fed infants.
Design and setting: Randomized clinical trial conducted from November 1992 to July 1998 in antenatal clinics in Nairobi, Kenya, with a median follow-up period of 24 months.
Participants: Of 425 HIV-1-seropositive, antiretroviral-naive pregnant women enrolled, 401 mother-infant pairs were included in the analysis of trial end points.
Interventions: Mother-infant pairs were randomized to breastfeeding (n = 212) vs formula feeding arms (n = 213).
Main outcome measures: Infant HIV-1 infection and death during the first 2 years of life, compared between the 2 intervention groups.
Results: Compliance with the assigned feeding modality was 96% in the breastfeeding arm and 70% in the formula arm (P<.001). Median duration of breastfeeding was 17 months. Of the 401 infants included in the analysis, 94% were followed up to HIV-1 infection or mortality end points: 83% for the HIV-1 infection end point and 93% to the mortality end point. The cumulative probability of HIV-1 infection at 24 months was 36.7% (95% confidence interval [CI], 29.4%-44.0%) in the breastfeeding arm and 20.5% (95% CI, 14.0%-27.0%) in the formula arm (P = .001). The estimated rate of breast milk transmission was 16.2% (95% CI, 6.5%-25.9%). Forty-four percent of HIV-1 infection in the breastfeeding arm was attributable to breast milk. Most breast milk transmission occurred early, with 75% of the risk difference between the 2 arms occurring by 6 months, although transmission continued throughout the duration of exposure. The 2-year mortality rates in both arms were similar (breastfeeding arm, 24.4% [95% CI, 18.2%-30.7%] vs formula feeding arm, 20.0% [95% CI, 14.4%-25.6%]; P = .30). The rate of HIV-1-free survival at 2 years was significantly lower in the breastfeeding arm than in the formula feeding arm (58.0% vs 70.0%, respectively; P = .02).
Conclusions: The frequency of breast milk transmission of HIV-1 was 16.2% in this randomized clinical trial, and the majority of infections occurred early during breastfeeding. The use of breast milk substitutes prevented 44% of infant infections and was associated with significantly improved HIV-1-free survival.
Comment in
- ACP J Club. 2000 Nov-Dec;133(3):99
- Breastfeeding in women with HIV.
Bulterys M. Bulterys M. JAMA. 2000 Aug 23-30;284(8):956; author reply 956-7. JAMA. 2000. PMID: 10944628 No abstract available. - Breastfeeding in women with HIV.
Coutsoudis A, Coovadia HM, Pillay K, Kuhn L. Coutsoudis A, et al. JAMA. 2000 Aug 23-30;284(8):956-7. JAMA. 2000. PMID: 10944629 No abstract available.
Similar articles
- Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial.
Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, Mwatha A, Ndinya-Achola J, Bwayo J, Kreiss J. Mbori-Ngacha D, et al. JAMA. 2001 Nov 21;286(19):2413-20. doi: 10.1001/jama.286.19.2413. JAMA. 2001. PMID: 11712936 Free PMC article. Clinical Trial. - Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M; Mashi Study Team. Thior I, et al. JAMA. 2006 Aug 16;296(7):794-805. doi: 10.1001/jama.296.7.794. JAMA. 2006. PMID: 16905785 Clinical Trial. - Interventions for preventing late postnatal mother-to-child transmission of HIV.
Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS. Horvath T, et al. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006734. doi: 10.1002/14651858.CD006734.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160297 Free PMC article. Review. - Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa.
Bobat R, Moodley D, Coutsoudis A, Coovadia H. Bobat R, et al. AIDS. 1997 Nov;11(13):1627-33. doi: 10.1097/00002030-199713000-00012. AIDS. 1997. PMID: 9365768 - Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Siegfried N, et al. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
Cited by
- What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis.
Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M, Walensky RP, Dabis F, Chu J, Rusibamayila A, Mushavi A, Freedberg KA. Ciaranello AL, et al. PLoS Med. 2012 Jan;9(1):e1001156. doi: 10.1371/journal.pmed.1001156. Epub 2012 Jan 10. PLoS Med. 2012. PMID: 22253579 Free PMC article. - Factors associated with viral load non-suppression among treatment-experienced pre-teenage children living with HIV in Kenya: a nationwide population-based cohort study, 2015-2021.
Mulinge MM, Kibui NK, Kimani H, Wainaina J, Bwana P, Omondi M, Wafula K, Wamalwa DC, Omondi EO, Nduati RW, Mwau M. Mulinge MM, et al. EClinicalMedicine. 2024 Feb 2;68:102454. doi: 10.1016/j.eclinm.2024.102454. eCollection 2024 Feb. EClinicalMedicine. 2024. PMID: 38333535 Free PMC article. - Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis.
Salado-Rasmussen K, Theilgaard ZP, Chiduo MG, Bygbjerg IC, Gerstoft J, Lüneborg-Nielsen M, Lemnge M, Katzenstein TL. Salado-Rasmussen K, et al. PLoS One. 2015 Mar 26;10(3):e0121111. doi: 10.1371/journal.pone.0121111. eCollection 2015. PLoS One. 2015. PMID: 25812161 Free PMC article. - Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC. Chung MH, et al. AIDS. 2005 Sep 2;19(13):1415-22. doi: 10.1097/01.aids.0000181013.70008.4d. AIDS. 2005. PMID: 16103773 Free PMC article. Clinical Trial. - The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.
Maddocks S, Dwyer D. Maddocks S, et al. Paediatr Drugs. 2001;3(9):681-702. doi: 10.2165/00128072-200103090-00006. Paediatr Drugs. 2001. PMID: 11688599 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical